CHICAGO, Sept. 08, 2016 -- Allscripts (NASDAQ:MDRX) announced today its latest initiative to improve population health, Allscripts eRecruit™ services. This multi-faceted initiative will offer services and technology to support physicians with referring patients to clinical trials, and life sciences and clinical research organizations to reduce clinical studies’ time and cost. This, in turn will help bring new treatments to the market more quickly.
Allscripts eRecruit, the initial offering of Allscripts Clinical Trials Solutions, enables more effective clinical trials recruitment from Allscripts broad provider network and large patient population. eRecruit focuses specifically on helping CROs determine if a trial is feasible within the Allscripts population, and facilitating enrollment of the qualified patients the trial requires. The solution also assists with recruiting patients to participate in these studies through engagements with their providers. This offering provides an avenue for clinical research and life sciences organizations to better recruit for treatment research, providers to find relevant clinical trials for their patients, and patients to engage in innovative care.
Allscripts is partnering with ePatientFinder® to further eRecruit’s patient matching, outreach and recruiting capabilities. The ePatientFinder Clinical Trial Exchange™ platform helps physicians learn about the latest clinical trial options for their patients to provide high-quality referrals.
“We very excited to partner with Allscripts to provide their large provider base access to the Clinical Trial Exchange, the only platform of its kind that leverages the trusted physician-patient relationship and EHR data to match patients with trials for advanced care,” said Tom Dorsett, CEO of ePatientFinder. "We applaud Allscripts for bringing eRecruit to both the provider and life-science communities.”
“Allscripts eRecruit is the latest way that Allscripts is connecting communities to foster population health,” said Jay Bhattacharyya, Allscripts Vice President and General Manager, Payer/Life Sciences. “Providers want to keep up with the latest research that helps improve patient outcomes. eRecruit helps providers better connect their patients to these clinical trials. We are excited to continue to expand our offerings in this space and lead the way in population health innovation.”
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta DiFranco 312-447-2466 [email protected]


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



